Illumina公布2025财年第一季度财务业绩 - 美通社
Illumina Reports Financial Results for First Quarter of Fiscal Year 2025 - PR Newswire
#Fiscal Year#Reports Financial#Financial Results#Illumina Reports#Newswire Illumina
生命科学资讯
生物技术与制药领域的最新动态
生产者细胞系：大规模基因疗法的关键制造者 - 《基因工程与生物技术新闻》
Producer Cell Lines: Large-Scale Gene Therapy Hitmakers - GEN - Genetic Engineering and Biotechnology News
#Cell Lines#Genetic Engineering#Gene Therapy#Large-Scale Gene#Therapy Hitmakers
Lonza集团（LZAGY）作为强劲势头股，值得买入吗？——纳斯达克
Lonza Group Ag (LZAGY) is a Great Momentum Stock: Should You Buy? - Nasdaq
#Momentum Stock#Great Momentum#Lonza Group#LZAGY#Stock
沃特世公司（NYSE:WAT）第一季度销售额超预期，下季度销售展望乐观——雅虎财经
Waters Corporation (NYSE:WAT) Posts Better-Than-Expected Sales In Q1, Next Quarter’s Sales Guidance is Optimistic - Yahoo Finance
#Sales Guidance#Waters Corporation#Yahoo Finance#Optimistic Yahoo#Finance Waters
沃特世宣布更新Empower软件以支持生物制品数据采集 - 光谱在线
Waters Announces Update to its Empower Software to Support Biologics Data Acquisition - Spectroscopy Online
#Announces Update#Empower Software#Support Biologics#Biologics Data#Data Acquisition
沃特世公司(WAT)第一季度财报预期——雅虎财经
What To Expect From Waters Corporation’s (WAT) Q1 Earnings - Yahoo Finance
#Waters Corporation#Yahoo Finance#Earnings Yahoo#WAT#Expect
Xcellerex 500升与2000升生物反应器 - GEN - 基因工程与生物技术新闻
Xcellerex 500 L and 2,000 L Bioreactors - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Bioreactors GEN#Genetic#GEN#Engineering
Cytiva与Asimov携手推进新一代细胞系设计与工艺开发 - 基因工程与生物技术新闻
Cytiva and Asimov Collaborate on NextGen Cell Line Design and Process Development - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Asimov Collaborate#Cell Line#Line Design#Process Development
Illumina五碱基解决方案：同步解码DNA与甲基化——专访Fiona Kaper
Decode DNA and Methylation Together with Illumina's 5 Base Solution | Interview with Fiona Kaper - Illumina
#Base Solution#Fiona Kaper#Decode DNA#Kaper Illumina#Illumina Decode
Cytiva推出两款新型Protein A树脂，提升单抗捕获成本效益——印度《生物光谱》
Cytiva develops two new protein A resins bringing cost efficiency to mAb capture - BioSpectrum India
#Cytiva develops#BioSpectrum India#resins bringing#bringing cost#cost efficiency
罗氏回应关税威胁，承诺向美国药品生产投资500亿美元——BioPharma Dive
Roche, answering tariff threat, pledges $50B to US drug production - BioPharma Dive
罗氏计划扩大并升级美国研究中心，作为其在该国500亿美元投资战略的一部分——Fierce Biotech报道
Roche looks to expand and upgrade US research centers as part of $50B investment strategy in the country - Fierce Biotech
罗氏投资500亿美元于美国以规避特朗普关税，创造1.2万个就业岗位——路透社报道。
Roche to invest $50 billion in US to avoid Trump tariffs, create 12,000 jobs - Reuters
#Trump tariffs#avoid Trump#Reuters Roche#jobs Reuters#create
罗氏效仿同行，向美国制造与研发基地投入500亿美元——FirstWord Pharma
Roche follows peers with $50B investment in US manufacturing, research sites - FirstWord Pharma
#research sites#FirstWord Pharma#Pharma Roche#investment#manufacturing
Cytiva扩充产品线，推出新型MabSelect树脂，采用可再生琼脂糖，助力单克隆抗体规模化、经济高效生产——Express Pharma报道
Cytiva expands portfolio with new MabSelect Resins made from renewable agarose for scalable, cost-efficient mAb manufacturing - Express Pharma
#Express Pharma#MabSelect Resins#Resins made#cost-efficient mAb#Cytiva expands
龙沙CHI创新战略内幕：面向未来的复杂药物胶囊技术 - 制药科技网
Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs - PharmTech.com
#Innovation Strategy#Lonza CHI#Future-Ready Capsules#Complex Drugs#Inside Lonza
解锁PROTACs在药物发现领域的潜力 - 科技网络
Unlocking the Potential of PROTACs in Drug Discovery - Technology Networks
#Drug Discovery#Technology Networks#Discovery Technology#Networks Unlocking#Potential
Illumina与Tempus联手通过基因组AI创新推动精准医疗未来发展 - 美通社
Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation - PR Newswire
#Tempus partner#precision medicine#Newswire Illumina#Tempus#Newswire
Ethris与Lonza专注于mRNA呼吸道疾病疫苗研发 - 制药技术
Ethris and Lonza focus on mRNA respiratory condition vaccines - Pharmaceutical Technology
#Pharmaceutical Technology#Lonza focus#mRNA respiratory#respiratory condition#Technology Ethris
Ethris与龙沙携手开发喷雾干燥mRNA疫苗，预防呼吸道疾病——BioSpace报道
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - BioSpace
#Lonza Collaborate#Respiratory Disease#Disease Prevention#Develop Spray-Dried#mRNA Vaccines